Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EARLY study of early versus delayed Aggrenox initiation after ischaemic stroke
2006-004870-28Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Apr 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in ischemic stroke comparing Early Aggrenox initiation with Delayed Aggrenox after aspirin lead-in (2 arms). Started Apr 2007; status: completed.
02
Drugs
dipyridamoleaspirin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on 2006-004870-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004870-28.